FAS and colorectal carcinoma: Prognostic analysis conducted on CRC patients with varying expression levels of CXCL1 (Figure 6B) and Fas (Figure 6C) using the Kaplan-Meier Plotter database indicated that high expression levels of CXCL1 and Fas were associated with higher survival rates in CRC patients.